Avizafone

Avizafone

Clinical data
Routes of administration	Intramuscular injection
ATC code	none
Identifiers
IUPAC name (2S)-2,6-diamino-N-{[(2-benzoyl-4-chlorophenyl)methylcarbamoyl]methyl}hexanamide
CAS Number	65617-86-9 Y
PubChem CID	71968
ChemSpider	64974 Y
UNII	65NK71K78P
ChEMBL	ChEMBL2103985 N
CompTox Dashboard (EPA)	DTXSID90215868
Chemical and physical data
Formula	C22H27ClN4O3
Molar mass	430.93 g·mol−1
3D model (JSmol)	Interactive image
SMILES Clc1cc(c(N(C(=O)CNC(=O)[C@@H](N)CCCCN)C)cc1)C(=O)c2ccccc2
InChI InChI=1S/C22H27ClN4O3/c1-27(20(28)14-26-22(30)18(25)9-5-6-12-24)19-11-10-16(23)13-17(19)21(29)15-7-3-2-4-8-15/h2-4,7-8,10-11,13,18H,5-6,9,12,14,24-25H2,1H3,(H,26,30)/t18-/m0/s1 Y Key:LTKOVYBBGBGKTA-SFHVURJKSA-N Y
NY (what is this?)  (verify)

Avizafone (Pro-Diazepam) is a water-soluble prodrug of the benzodiazepine derivative diazepam. It can be administered intramuscularly.

Avizafone is metabolised by enzymes in the blood to form the active drug diazepam. It is used mainly as an antidote to poisoning with organophosphate nerve agents.

See also

• Alprazolam triazolobenzophenone
• Rilmazafone